HCP (NYSE:HCP) stock is expected to deviate a maximum of $6.26 from the average target price of $31.29 for the short term period. 7 Street Experts have initiated coverage on the stock with the most promising target being $43 and the most muted being $23.
Shares of HCP, Inc. rose by 3.72% in the last five trading days and 6.86% for the last 4 weeks. HCP, Inc. is up 10.29% in the last 3-month period. Year-to-Date the stock performance stands at -4.45%.
HCP (NYSE:HCP) has an average broker rating of 3.37, which is interpreted as a Hold, as rated by 9 equity analysts. 1 other analysts advise a Buy. Nevertheless, the majority of 5 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 2 brokerage firm advices Strong Sell on the share due to lack of confidence about the future of the company. 1 considers that the stock is a Sell.
HCP (NYSE:HCP): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $35.46 and $34.83 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $35.58. The buying momentum continued till the end and the stock did not give up its gains. It closed at $35.38, notching a gain of 0.03% for the day. The total traded volume was 3,531,159 . The stock had closed at $35.37 on the previous day.
In an insider trading activity, Hsiao Kai, officer (Executive Vice President) of Hcp, Inc., unloaded 266 shares at an average price of $36.04 on May 9, 2016. The total amount of the transaction was worth $9,587, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.